input stringlengths 798 36.8k | output stringlengths 218 19.2k | __index_level_0__ int64 0 214k |
|---|---|---|
Target Study Title: Evaluation of the HF20™ Filter for Pediatric Continuous Renal Replacement Therapy (CRRT)
Target Study Description: #Study Description
Brief Summary
Historically, innovations for acute kidney injury (AKI) and continuous renal replacement therapy (CRRT) have centered around an adult population. Howe... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Receiving or plan to receive CRRT with the HF20™ filter as standard of care
* Acute kidney injury (AKI) or fluid overload as defined as one of the two below:
1. AKI defined as Kidney Disease Improving Global Outcomes (KDIGO) Stage 1 or higher by eith... | 0 |
Target Study Title: Safety and Tolerability of Multiple Ascending Doses of LY2140023 in Subjects With Schizophrenia
Target Study Description: #Study Description
Brief Summary
This is an inpatient, open-label, multiple-dose, multicenter study to evaluate the safety and tolerability of LY2140023 given at doses expected... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Have a diagnosis of schizophrenic disorder
* Female participants who test negative for pregnancy at screening and agree to use a reliable method of birth control for the duration of the study and for at least 3 months after the last LY2140023 dose or ar... | 1 |
Target Study Title: An Alternative Technique for Measuring Blood Pressure
Target Study Description: #Study Description
Brief Summary
This cross design study will be conducted to evaluate the combination of palpation and auscultation techniques as an alternative technique for the measurement of blood pressure. The mai... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion criteria:
* Over 18 years,
* no chronic disease,
* not taking any medication and/or treatment that affects the cardiovascular or circulatory system,
* volunteering to participate in the research.
Exclusion Criteria:
* has a chronic disease,
* taking medication th... | 2 |
Target Study Title: A Phase 2, Open-label Study of Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Target Study Description: #Study Description
Brief Summary
This is an open-label, multicenter, phase 2 clinical trial to evaluate the antitumor activity of brentuximab vedotin as a single... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Histologically-confirmed by central review CD30-positive nonlymphomatous malignancy
* Have failed, refused, or have been deemed ineligible for standard therapy
* Measurable disease
* Eastern Cooperative Oncology Group (ECOG) Performance Status score of ... | 3 |
Target Study Title: COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae (COLUMBIA CARDS) Registry
Target Study Description: #Study Description
Brief Summary
COLUMBIA CARDS is a pilot study to understand how COVID-19 affects the heart. It is known that COVID-19 can affect the heart in di... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Convalescent COVID-19 patient
* If COVID-19 patient, at least 4 weeks after beginning of symptoms, and at least 2 weeks after hospital discharge if had been hospitalized.
* Control patients who have had a negative COVID-19 screening without prior positi... | 4 |
Target Study Title: Comparison of Two Different Anesthesia Methods During Oocyte Retrieval for in Vitro Fertilization
Target Study Description: #Study Description
Brief Summary
In this study; during the oocyte retrieval procedure, it was aimed to compare two different general anesthesia methods, in which propofol was... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Over 18 years
* ASA I-II
* Patients who underwent oocyte retrieval for IVF treatment
Exclusion Criteria:
* The patient does not want to participate
* ASA > II patients
* Patients under 18 years
* Patients who are allergic to the drugs used
* Patients ... | 5 |
Target Study Title: Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid
Target Study Description: #Study Description
Brief Summary
This study seeks to evaluate a treatment for multiple full thickness chondral ... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria: MRI-confirmed full-thickness unipolar or bipolar chondral lesion(s) from osteoarthritis.
Exclusion Criteria:
* Inflammatory arthritis
* Body mass index (BMI) greater than 35
* Presence of significant varus or valgus knee instability or unusually stiff kn... | 6 |
Target Study Title: Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
Target Study Description: #Study Description
Brief Summary
This study is being done to develop a new method that can rapidly stage patients with gastric and pancreas cancer. Staging means finding out what is the extent of the ca... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Men and women 18 years and older
* Informed consent in keeping with the policies of Memorial Sloan-Kettering Cancer Center
* Presentation of gastric or pancreatic cancer based on objective findings by either:
* CT scan
* Endoscopy
* Pathologic ex... | 7 |
Target Study Title: An Open Label, Two Way Crossover, Balanced, Single Dose, Comparative Evaluation of Relative Bioavailability of Tacrolimus Capsules 5 mg With That of 'Prograf' Capsules 5 mg in Healthy Subjects Under Fasting Conditions.
Target Study Description: #Study Description
Brief Summary
The purpose of this ... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* The subjects should be healthy human between 18 and 45 years.
* The subjects should be screened within 21 days prior to the administration of first dose of the study drug.
* The subjects should have a BMI between 18.5 and 24.9 weight in kg/ height2 in m... | 8 |
Target Study Title: Pharmacodynamic and Pharmacokinetic Properties of Insulin Glulisine (Apidra) in Comparison to Insulin Lispro (Humalog) in Healthy Lean and Obese Subjects
Target Study Description: #Study Description
Brief Summary
Primary objective
* To investigate pharmacodynamic and pharmacokinetic parameters af... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion criteria :
* Normal HbA1c
* Women have to either be postmenopausal, surgically sterilized, or not pregnant and using adequate contraception.
Exclusion criteria :
* Systemic concomitant medication
Sex :
ALL
Ages :
- Minimum Age : 18 Years
- Maximum Age : 65 Yea... | 9 |
Target Study Title: A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.
Target Study Description: #Study Description
Brief Summary
This study will assess the efficacy of a 12-week treatment with darifenacin in increasing warning time, the time from... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Three symptoms of OAB (urge incontinence, frequency and urgency) for at least six months prior to Visit 2.
* Patients capable of independent toileting and able of independently completing the patient diary.
Exclusion Criteria:
* Patients in whom the u... | 10 |
Target Study Title: The Effect of Muscular Strength Training in Patients With Drug Addiction
Target Study Description: #Study Description
Brief Summary
Physical health does not have a high priority in today's treatment of patients with substance use disorder (SUD). SUD patients have a poor physical health not only du... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* being treated for drug abuse
* not using drugs during intervention period
Exclusion Criteria:
* participated in strength training in previous 6 months
* cardiovascular disease
* any other disease that impedes to finish tests
* not showing up for testi... | 11 |
Target Study Title: Patient Empowerment Through Predictive Personalised Decision Support (PEPPER)
Target Study Description: #Study Description
Brief Summary
Patient Empowerment through Predictive PERsonalised decision support (PEPPER) is an European Union (EU) funded research project to develop a personalised clinica... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Adults >=18years of age
* Diagnosis of T1DM for > 1 year
* On MDI using a basal-bolus insulin regime or CSII (insulin pump) for at least 6 month
* Structured education done and good ability perform carbohydrates (CHO) counting
* HbA1c >= 48mmol/mol and ... | 12 |
Target Study Title: Phase II Trial of Gemcitabine-Eribulin (GE) in Cisplatin Ineligible Patients With Advanced or Unresectable Urothelial Carcinoma of the Bladder
Target Study Description: #Study Description
Brief Summary
This phase II trial studies how well gemcitabine hydrochloride and eribulin mesylate work in tre... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Patients must have locally advanced or metastatic predominantly urothelial carcinoma of the bladder, ureter, or urethra that is not amenable to curative surgical treatment
* Patients must have histologically confirmed predominantly urothelial carcinoma ... | 13 |
Target Study Title: Enhancing Medication Safety in Children With Polypharmacy Using Parent- Reported Symptom Assessments
Target Study Description: #Study Description
Brief Summary
This study plans to learn about how to measure symptoms (like tiredness or rash) in children with special healthcare needs who take 5 or m... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Neurological impairment
* 5 or more scheduled medications
* English- or Spanish-speaking
Exclusion Criteria:
* Receives primary care outside outside of the Children's Hospital Colorado Network of Care
Sex :
ALL
Ages :
- Minimum Age : 1 Day
- Maximu... | 14 |
Target Study Title: Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach
Target Study Description: #Study Description
Brief Summary
The goal of this prospective, interventional, non-randomized study was to compare pain score in unilateral and bilateral po... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* All upper abdominal malignancy adult patients
* on palliative care,
* having a visual analog scale (VAS) of more than 7
Exclusion Criteria:
* Patients on anti-coagulant medications,
* having an INR > 1.50 and or
* Platelets count < 80000,
* inability ... | 15 |
Target Study Title: Psychometric Testing of the Norwegian Version of the Comfort Behavioral Scale
Target Study Description: #Study Description
Brief Summary
The purpose of this study is to establish reliability and validity of the Norwegian version of the Comfort behavioral scale.
Detailed Description
Structured pa... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Younger than 3 years at the time of surgery
* Day care patients admitted for minor elective surgery
Exclusion Criteria:
* Pre-entry use of sedation and/or analgesics
* Neurological or other diseases or drugs (neuromuscular blockers) thet significantly... | 16 |
Target Study Title: A Randomised Controlled Trial Investigating the Efficacy and Effectiveness of Text Message Reminders to Improve Uptake of Breast Screening by Prevalent Women Living in the London Borough of Hillingdon
Target Study Description: #Study Description
Brief Summary
Breast Cancer is the single most commo... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
Women aged 47 <= age <= 53 years, being invited for their first breast screen, without a history of breast disease or malignancy, living in the London Borough of Hillingdon, were eligible for inclusion in the trial.
Exclusion Criteria:
Women with a hist... | 17 |
Target Study Title: Examining the Effect of a Behavioural-based Intervention on Injury Prevention Program Adherence in Canadian Female Youth Soccer Players
Target Study Description: #Study Description
Brief Summary
Soccer accounts for more than 10% of all sport injuries in youth requiring medical attention. The injur... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* 14 or U-16 female soccer team competing in a Calgary Minor Soccer Association league at the commencement of the 2013 outdoor season and/or the 2013 <= age <= 2014 indoor season and/or the 2014 outdoor season
* Female youth soccer player (ages 13 <= age ... | 18 |
Target Study Title: Conversion of Twice-a-day Tacrolimus to Once-Daily Tacrolimus Extended-Release Formulation in Stable Pediatric Kidney Transplant Recipients
Target Study Description: #Study Description
Brief Summary
This study was designed to compare the pharmacokinetics of Prograf and Advagraf in stable pediatric... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* ABO-compatible kidney-only transplantation
* more than 1 year after kidney transplantation
* 5 <= age <= 15 old
* patients maintained on Prograf
* tacrolimus level of determined previously: 4 to 20 ng/ml
* eGFR by Schwartz equation > 50mL/min
Exclusion... | 19 |
Target Study Title: Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
Target Study Description: #Study Description
Brief Summary
This research study will assess cruciferous vegetable intake in patients presenting for screening colonoscopy and correlate intake with histone status and hi... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion criteria:
* scheduled for screening colonoscopy
* off NSAID or aspirin therapy in accordance with OHSU endoscopy clinic guidelines
* INR 0.90 <= age <= 1.20
* hemoglobin >= 13.5 (men) or 12.0 (women)
* platelets >=100,000/μL
* Chem screen results within normal limi... | 20 |
Target Study Title: Phase I Trial to Evaluate the Safety of Platelet Derived Growth Factor B (PDGF-B) and a Limb Compression Bandage in Venous Leg Ulcers
Target Study Description: #Study Description
Brief Summary
Most chronic (long-lasting) wounds of the leg (also known as venous ulcers) fail to heal in a reasonable ... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Patient must have a venous leg ulcer.
* Patient must have failed at least 6 weeks of limb compression.
* Wound must be free of necrotic debris.
* Wound must be greater than 5 cm2 and less than 20 cm2.
* Wound must be more than 6 months old.
* Affected l... | 21 |
Target Study Title: Effects of Shockwave Therapy on Crouched Gait and Hamstring Flexibility in Children With Diplegic Cerebral Palsy.
Target Study Description: #Study Description
Brief Summary
Randomized controlled trial will be conducted on thirty-two cerebral palsy children in Punjab Special School. Spastic Diplegi... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Children with GMFCS level I, II & III.
* Passive range of motion of knee extension is limited to 20 degree with hip 90 degree.
* Age between 6 <= age <= 12.
Exclusion Criteria:
* Children with epileptic history
* Previous muscular lengthening techniqu... | 22 |
Target Study Title: Early Warning for Desaturation by Oxygen Reserve Index During Induction of General Anesthesia
Target Study Description: #Study Description
Brief Summary
During the induction of general anesthesia, the anesthesiologist needs to provide the oxygen supply to meet the patient's needs continuously. In ... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Male and female patients aged 18 <= age <= 80 with ASA physical status I to III scheduled for elective surgery with planned arterial catheter placement before induction of general anesthesia.
Exclusion Criteria:
* Age <18 years
* Inability to give pri... | 23 |
Target Study Title: A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Target Study Description: #Study Description
Brief Summary
The primary objective of this study is to evaluate the ... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ulcerative colitis (UC) established >= 3 months before baseline by clinical and endoscopic evidence and corroborated by a histopathology report.
* Moderate to severe active UC as defined by a total Mayo score of 6 to 12 with a centrally rea... | 24 |
Target Study Title: Phase IV Study of Coronally Advanced Flap With or Without Porcine Collagen Matrix for Treatment of Gingival Recession: a Randomized Controlled Clinical Trial
Target Study Description: #Study Description
Brief Summary
The purpose of this study is to compare the clinical outcomes after coronally adv... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Age >= 18 years.
* Presence of at least one Class I or II Miller gingival recession >= 2 mm in maxillary canines or premolars with identifiable cementum-enamel junction (CEJ) and without deep non-carious cervical lesions (< 0.5 mm): A + (Pini-Prato et a... | 25 |
Target Study Title: An Observational Study 'FOLLITROPIN' Comparing the Efficacy of Follitropin Alpha Biosimilar: the Real-world Data
Target Study Description: #Study Description
Brief Summary
Aim to investigate the efficacy of follitropin alpha biosimilar therapy (Primapur®) in nonselected real-world population.
Det... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Women with established causes of infertility and indications for the use of ART methods, according to the Order of the Ministry of Health of the Russian Federation 'On the use of assisted reproductive technologies, contraindications and limitations to t... | 26 |
Target Study Title: Ultracet (Tramadol HCL [37.5 mg]/Acetaminophen [325 mg]) Combination Tablets in the Treatment of the Pain of Fibromyalgia
Target Study Description: #Study Description
Brief Summary
The purpose of this study is to evaluate the analgesic effect of combination of tramadol hydrochloride and acetaminop... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Participants must meet the American College of Rheumatology 1990 criteria for the classification of fibromyalgia (that are, Participants must have had widespread pain [pain in three quadrants and in the axial skeleton] for at least three months and pain... | 27 |
Target Study Title: Sleep Apnea. Concordance Between Non-reference and Reference Centres
Target Study Description: #Study Description
Brief Summary
When a disorder is as prevalent as sleep apnea hypopnea syndrome various medical levels and strategies should be implicated. We to evaluate the degree of concordance in m... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Supected sleep apnea
Exclusion Criteria:
* Major diseases
Sex :
ALL
Ages :
- Minimum Age : 18 Years
- Maximum Age : 70 Years
- Age Group (Child: birth-17, Adult: 18-64, Older Adult: 65+) : OLDER_ADULT, ADULT
Accepts Healthy Volunteers:
No
</FORM... | 28 |
Target Study Title: Repetitive TMS of the Precuneus: a Randomized Double-blinded Placebo-controlled Trial in Alzheimer's Disease Patients.
Target Study Description: #Study Description
Brief Summary
Alzheimer's disease is a global health challenge. Efforts aim at developing an effective treatment able to meet the need... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* The patient and the responsible caregiver have signed the Informed Consent Form.
* The patient has probable AD, diagnosed according to NINCDS-ADRDA criteria.
* The patient is a man or woman, aged <= 85 years.
* The patient has a CDR total score of 0.5 o... | 29 |
Target Study Title: Defining the Role of ERCP in the Evaluation and Treatment of Idiopathic Recurrent Acute Pancreatitis
Target Study Description: #Study Description
Brief Summary
The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs ... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Idiopathic recurrent acute pancreatitis, defined as two or more episodes requiring hospitalization
* ERCP with SOM planned
Exclusion Criteria:
* Chronic pancreatitis
* Pancreas divisum
* Alternate etiology identified (e.g., CBD stone, IPMN)
* Inabilit... | 30 |
Target Study Title: An Open, Comparative Phase II Study of Immediate Versus Delayed Treatment With Topotecan HCl Given as a Continuous 21-Day Infusion Every 28 Days to Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy
Target Study Description: #Study Description
Brief Summary
The purpose of this s... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are HIV-positive.
* Have PML, including symptoms of PML.
* Are able to complete the study.
* Agree to have a catheter inserted in a vein.
* Have taken at least 3 weeks of a stable anti-HIV drug combinatio... | 31 |
Target Study Title: Clinical Outcomes in Pediatric Plasmodium Falciparum Malaria According to Host Cytoadherence Factors
Target Study Description: #Study Description
Brief Summary
The purpose of this study is to determine the importance of key blood group molecules in the clinical outcome of Plasmodium falciparum mal... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of Plasmodium falciparum malaria infection
Exclusion Criteria:
* HIV or significant malnutrition
Sex :
ALL
Ages :
- Minimum Age : 6 Months
- Maximum Age : 12 Years
- Age Group (Child: birth-17, Adult: 18-64, Older Adult: 65+) : C... | 32 |
Target Study Title: Safety & Immunogenicity of a Booster Dose of dTPa Vaccine (Boostrix®) Co-admnd. With Aventis Pasteur's Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Vaccine (Menactra™) vs Admn. of Either Vaccine Alone in Healthy Adolescents
Target Study Description: #Study Description
Brief Summary
... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Healthy subjects as established by medical history and history-directed physical examination before entering into the study.
* Previously completed routine childhood vaccinations against diphtheria, tetanus and pertussis diseases according to the recomm... | 33 |
Target Study Title: Phase I Study of Neoadjuvant Nivolumab in Patients With Non-metastatic High-risk Clear Cell Renal Cell Carcinoma
Target Study Description: #Study Description
Brief Summary
This study will evaluate the use of nivolumab before surgery in patients with high-risk clear cell renal cell carcinoma who ar... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria (abbreviated):
* Confirmed non-metastatic high-risk clear cell renal cell carcinoma (T2a-T4NanyM0 or TanyN1M0)
* Schedule to undergo either partial or radical nephrectomy as part of treatment plan
* Patient agrees to have a tumor biopsy
* ECOG performance ... | 34 |
Target Study Title: The Effect of the Popliteal Plexus Block on Postoperative Opioid Consumption, Pain, Muscle Strength and Mobilization After Total Knee Arthroplasty - a Randomized, Controlled, Blinded Study
Target Study Description: #Study Description
Brief Summary
In this study we wish to investigate the analgesic... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Scheduled to undergo primary total knee arthroplasty in spinal anesthesia
* Able to perform a Timed Up and Go (TUG) test
* Age > 50 years
* Ability to give their written informed consent to participating in the study after having fully understood the co... | 35 |
Target Study Title: Efficacy of Specified Manual Therapies in Combination With a Supervised Exercise Protocol on Managing Pain Intensity and Functional Disability in Patients With Knee Osteoarthritis
Target Study Description: #Study Description
Brief Summary
Osteoarthritis (OA) is referred to a group of conditions th... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* aged between 47 <= age <= 60;
* mild to moderate pain in one/both knees for 3-months;
* the pain intensity score between 2 to 6 on NPRS;
* morning stiffness <30-minutes;
* Self-reported crepitus on knee motion;
* grade 1 to 3 on Kellgren-Lawrence radiog... | 36 |
Target Study Title: Comparison of Efficacy, Safety and Economic Outcomes Between Once-Daily Versus Twice-Daily Amikacin in Combination With Cloxacillin in Febrile Neutropenic Children
Target Study Description: #Study Description
Brief Summary
Once-daily dose administration of aminoglycoside in adults is effective and... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Aged 1 year - 14 years
* A single oral temperature of >= 38.3 degrees C; or >= 38.0 degrees C for >= 1 hour.
* Neutropenia: neutrophil count, < 500/cu mm or <1,000/cu mm with a predicted decrease to <500/mm3.
* During the course of chemotherapy
Exclusi... | 37 |
Target Study Title: Benefit of Assistive Listening Device for Lateralization and Spatial Hearing
Target Study Description: #Study Description
Brief Summary
Speech intelligibility in noise will be evaluated in adults with moderate to moderate-severe sensorineural hearing loss using a Phonak Roger microphone and hearin... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Experienced hearing aid users, age >= 18 years
* Bilateral, symmetric moderate to moderate-severe sensorineural hearing loss
* Good understanding of the English language
* Health outer ear as confirmed by otoscopy
* Informed consent as documented by sig... | 38 |
Target Study Title: Efficacy of Sterile Dressing in the Prevention of of Peripheral Intravenous Catheters Associated Phlebitis in Patients From the Western Brazilian Amazon: Pragmatic, Randomized, Blinded and Controlled Trail
Target Study Description: #Study Description
Brief Summary
Pragmatic, randomized, single-bli... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* IV access for more 48 hours obtained in the studied wards.
* IV access 20 and 22 G.
* without confusion or agitation
* Aged more or equal 18 years
Exclusion Criteria:
* Sepsis
* Skin lesions
Sex :
ALL
Ages :
- Minimum Age : 18 Years
- Age Group (Ch... | 39 |
Target Study Title: Can FloSeal Reduce the Risk of Intra-abdominal Bleeding After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Performed for the Treatment of Peritoneal Carcinomatosis ?
Target Study Description: #Study Description
Brief Summary
Introduction
Modern treatment of peritoneal carci... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Male and female patients older than 18 year old
* All cases of PC regardless of primary tumour (colorectal carcinoma, peritoneal mesothelioma, appendiceal carcinoma etc.)
Exclusion Criteria:
* Prophylactic HIPEC
* Peritoneal Carcinomatosis Index (PCI)... | 40 |
Target Study Title: A Randomized, Multi-center, Double-blinded, Placebo-controlled Phase 3 Study of Nivolumab and Ipilimumab, Nivolumab Monotherapy, or Placebo in Combination With Trans-arterial ChemoEmbolization (TACE) in Patients With Intermediate-stage Hepatocellular Carcinoma (HCC)
Target Study Description: #Study ... | <FORMATTED_CRITERIA>
#Eligibility Criteria:
Inclusion Criteria:
* Participant has intermediate-stage hepatocellular carcinoma (HCC) whose tumor characteristics exceed the Beyond Milan and Up-to-7 (BMU7) criteria and is eligible for trans-arterial ChemoEmbolization (TACE)
* Participant has no extrahepatic spreading (EH... | 41 |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 6